ArticleJournal of clinical medicine2025

Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation.

M Rosa Dalmau Llorca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.